| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | US7041665 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 05/09/2006 | US7041662 Substituted benzo [b] azepin-2-one compounds |
| 05/09/2006 | US7041652 administering ascorbic acid, ascorbate or a derivative thereof in combination with quercetin-3-O-glucoside (isoquercetin), quercetin-4'-glucoside, quercetin-3'-glucoside, or quercetin-7-glucoside to increase bioavailability |
| 05/09/2006 | US7040314 Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
| 05/09/2006 | CA2418908C 1,4-dihydropyridines as bradykinin antagonists |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/04/2006 | WO2006047492A2 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 05/04/2006 | WO2006046916A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046915A1 Use of unsaturated quionoline or naphtalene derivatives as medicaments |
| 05/04/2006 | WO2006046914A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046739A1 Remedy for inflammatory diseases |
| 05/04/2006 | WO2006046661A1 Interleukin-6 inhibitor |
| 05/04/2006 | WO2006046527A1 Solid pharmaceutical preparation dissolved in oral cavity |
| 05/04/2006 | WO2006046492A1 Novel ppar regulating agent and method of screening the same |
| 05/04/2006 | WO2006046123A2 Conjugates with anti-inflammatory activity |
| 05/04/2006 | WO2006045552A1 Purine derivatives for use as adenosin a-2a receptor agonists |
| 05/04/2006 | WO2006045505A1 Mif-inhibitors |
| 05/04/2006 | WO2006045238A1 Carbonized pollen and the use thereof for the preparation of anticancer drugs |
| 05/04/2006 | WO2006036512A3 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 05/04/2006 | WO2006036497A3 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 05/04/2006 | WO2006013376A3 Drug delivery of a cox inhibitor from embolic agents |
| 05/04/2006 | WO2005112965A3 Botanical anti-inflammatory compositions and methods |
| 05/04/2006 | WO2005106492A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3) |
| 05/04/2006 | US20060094751 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 05/04/2006 | US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma |
| 05/04/2006 | US20060094735 Compounds for cell proliferation, anticancer agents, kinesin inbiitors |
| 05/04/2006 | US20060094729 metastatic or non-metastatic prostate cancer; for inducing apoptosis |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094724 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094718 O-substituted hydroxyaryl derivatives |
| 05/04/2006 | US20060094701 Respiratory system disorders; antiinflamamtory agents; side effect reduction; administering terbutaline |
| 05/04/2006 | US20060094647 Treatment of inflammatory bowel disease using growth factors |
| 05/04/2006 | US20060093604 Method of treatment and prophylaxis |
| 05/04/2006 | US20060093602 Inflammatory mediator antagonists |
| 05/04/2006 | US20060093598 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093576 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/04/2006 | CA2585711A1 Conjugates with anti-inflammatory activity |
| 05/04/2006 | CA2584413A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2584409A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2584167A1 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 05/04/2006 | CA2582434A1 Purine derivatives for use as adenosin a-2a receptor agonists |
| 05/04/2006 | CA2581981A1 Mif-inhibitors |
| 05/03/2006 | EP1652847A1 Quinoline and quinazoline derivatives for the treatment of tumors |
| 05/03/2006 | EP1652530A1 Drug promoting ceramide transport, base sequence for producing the drug, method of measuring activity of promoting ceramide release and method of measuring activity of promoting intermembrane ceramide transfer |
| 05/03/2006 | EP1652515A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 05/03/2006 | EP1651641A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651640A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651638A1 Pyridyl piperazinyl ureas |
| 05/03/2006 | EP1651634A1 Imidazol derivatives of piperidine as histamine antagonists |
| 05/03/2006 | EP1651629A1 Substituted benzothiophene compounds and uses thereof |
| 05/03/2006 | EP1651610A1 Quinoline derivates and their use in therapy |
| 05/03/2006 | EP1651342A2 Combinatorial synthesis on support |
| 05/03/2006 | EP1651232A2 Compounds for inflammation and immune-related uses |
| 05/03/2006 | EP1651228A1 Use of quinazoline tyrosine kinase inhibitors in the treatment of inflammatory processes |
| 05/03/2006 | EP1651212A1 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents |
| 05/03/2006 | EP1651205A1 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
| 05/03/2006 | EP1651199A1 Method and preparation for reducing irritation and/or inflammatory reaction in human skin |
| 05/03/2006 | EP1651198A2 Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases |
| 05/03/2006 | EP1572178B1 Treatment of mastalgia with 4-hydroxy tamoxifen |
| 05/03/2006 | EP1562902B1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/03/2006 | EP1560828B1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 05/03/2006 | EP1546128B1 Pyrimidine derivatives as selective cox-2 inhibitors |
| 05/03/2006 | EP1515955A4 Chemical process |
| 05/03/2006 | EP1513836B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 05/03/2006 | EP1505930A4 Drug-delivery endovascular stent and method for treating restenosis |
| 05/03/2006 | EP1499611A4 Process for 5- 2(r)- 1(r)- 3,5-bis(trifluoromethyl)phenyl|ethoxy|-3(s)-(4-fluorophenyl)-4-morpholinyl|methyl|-1,2-dihydro-3h-1,2,4-triazol-3-one |
| 05/03/2006 | EP1448986B1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 05/03/2006 | EP1425005B1 Pharmaceutical compostion comprising lumiracoxib |
| 05/03/2006 | EP1390351B1 Pyrimidine derivatives useful as selective cox-2 inhibitors |
| 05/03/2006 | EP1389129A4 Methods of treating respiratory conditions |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1235558B1 Compressed tablet composition comprising a nsaid |
| 05/03/2006 | EP1210065B1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 05/03/2006 | EP1153017B1 Bicyclic compounds and their use as integrin receptor ligands |
| 05/03/2006 | EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent |
| 05/03/2006 | EP1074542B1 Sulfonamide-containing indole compounds |
| 05/03/2006 | EP0927217B1 Angiogenic inhibitory compounds |
| 05/03/2006 | CN2776403Y Anti inflammation pain relieving plaster |
| 05/03/2006 | CN1768064A Thiadibenzoazulene derivatives for the treatment of inflammatory diseases |
| 05/03/2006 | CN1768050A Benzopyran compounds useful for treating inflammatory conditions |
| 05/03/2006 | CN1767870A Otorhinological delivery device |
| 05/03/2006 | CN1767835A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 05/03/2006 | CN1767824A Photostabilized topical formulations of KETOPROFEN |
| 05/03/2006 | CN1767819A Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 05/03/2006 | CN1767078A Preparation of radium-223, physically accepted preparation and kit |
| 05/03/2006 | CN1765416A Health caring plaster |
| 05/03/2006 | CN1765388A Quick-acting pain-alleviating broad-spectrum compound formulation |
| 05/03/2006 | CN1765366A Peony total glucosides tablet and its preparation method |
| 05/03/2006 | CN1765361A Novel bulleyaconitine A powder injection and its production method |
| 05/03/2006 | CN1254479C 3-methylene steroid derivative |
| 05/03/2006 | CN1254478C Derivatives of monosaccharides as well adhesion inhibitors |
| 05/03/2006 | CN1254236C Lyophilized preparation of civeleth sodium |
| 05/03/2006 | CN1254234C Plasmid DNA (Lipogenes TM) and encapsulating therapeutica agent containing karyon-positioning signal /fusion-promoting peptide conjugate into targeted liposomes complex |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038073 Synthesis of 2-alkyl amino acids |
| 05/02/2006 | US7038061 Analgesics; anesthetics; antiinflammatory agents; central nervous system duisorders; strokes; antiarthritic agents; inflammatory bowel disorders |
| 05/02/2006 | US7038055 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |